nuvilexNuvilex, Inc. is a clinical-stage, biotechnology company based in Silver Spring, Maryland that specializes in the development of commercialized treatments for brain cancer, breast cancer, prostate cancer, pancreatic cancer, and diabetes through the use of live-cell encapsulation technology known as Cell-in-a-Box. This innovative technology will serve as a platform for building treatments for other life-threatening diseases. Nuvilex, Inc. trades in the OTC market under the symbol NVLX.

Nuvilex’s live-cell encapsulation technology is a method that encloses approximately 10,000 living cells in a protective cocoon roughly the size of a pin’s head. The capsules are robust and can withstand external forces, thus allowing them to be implanted using catheters or needles without any damage. Depending on the cell types being used, the cells encapsulated may be employed to develop treatments for serious and even deadly diseases.

Primarily focusing on the development of treatment for advanced, inoperable pancreatic cancer, Nuvilex combines infosfamide, the anti-cancer drug, with Cell-in-a-Box technology—converting infosfamide into an active, cancer-killing form. As of present, the company has completed half of their clinical trials in inoperable pancreatic cancer treatment, as well as in their research studies for diabetes treatment.

Through Medical Marijuana Science, Inc., the company’s subsidiary, Nuvilex aims to search for ways to exploit the use of its live-cell encapsulation technology to optimize the effectiveness of chemical constituents of cannabinoids against cancers while simultaneously minimizing or eliminating the incapacitating side effects often associated with treatments for cancer. Medical Marijuana Sciences, therefore, is given the opportunity to create a greener approach to battling fatal cancers that take the lives of hundreds of thousands across the globe every single year.

The company also develops information technology for third parties, and distributes nutraceutical formulations. It manufactures and distributes an extensive range of products, including Oraphyte, Talsyn, Infinitink, Cinnechol, Citroxin, Cinnergen, Cyclosurface, Cinnsational, and PurEffect.

Founded in 1996 under the name, Inc., Nuvilex, Inc. officially changed its name in 2009.

Yahoo! Finance: NVLX News

Latest Financial News for NVLX